vida: extract claims from 2020-03-17-pnas-us-life-expectancy-stalls-cvd-not-drug-deaths #2318

Closed
vida wants to merge 1 commit from extract/2020-03-17-pnas-us-life-expectancy-stalls-cvd-not-drug-deaths-0f6b into main
Member

Automated Extraction

Source: inbox/queue/2020-03-17-pnas-us-life-expectancy-stalls-cvd-not-drug-deaths.md
Domain: health
Agent: Vida
Model: anthropic/claude-sonnet-4.5

Extraction Summary

  • Claims: 1
  • Entities: 0
  • Enrichments: 2
  • Decisions: 0
  • Facts: 4

1 claim, 2 enrichments. The claim is highly novel because it quantitatively inverts the dominant public narrative about what's driving US life expectancy stagnation. The 3-11x ratio is the key mechanism insight. Enrichments challenge the 'deaths of despair' framing and confirm the Big Food/metabolic disease claim with hard numbers. This is a foundational mechanism paper that deserves extraction despite being in a well-covered topic area because it makes a specific quantitative argument the KB doesn't yet contain.


Extracted by pipeline ingest stage (replaces extract-cron.sh)

## Automated Extraction **Source:** `inbox/queue/2020-03-17-pnas-us-life-expectancy-stalls-cvd-not-drug-deaths.md` **Domain:** health **Agent:** Vida **Model:** anthropic/claude-sonnet-4.5 ### Extraction Summary - **Claims:** 1 - **Entities:** 0 - **Enrichments:** 2 - **Decisions:** 0 - **Facts:** 4 1 claim, 2 enrichments. The claim is highly novel because it quantitatively inverts the dominant public narrative about what's driving US life expectancy stagnation. The 3-11x ratio is the key mechanism insight. Enrichments challenge the 'deaths of despair' framing and confirm the Big Food/metabolic disease claim with hard numbers. This is a foundational mechanism paper that deserves extraction despite being in a well-covered topic area because it makes a specific quantitative argument the KB doesn't yet contain. --- *Extracted by pipeline ingest stage (replaces extract-cron.sh)*
vida added 1 commit 2026-04-04 13:18:32 +00:00
- Source: inbox/queue/2020-03-17-pnas-us-life-expectancy-stalls-cvd-not-drug-deaths.md
- Domain: health
- Claims: 1, Entities: 0
- Enrichments: 2
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
Member

Eval started — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet)

teleo-eval-orchestrator v2

**Eval started** — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet) *teleo-eval-orchestrator v2*
Owner

Validation: PASS — 1/1 claims pass

[pass] health/cvd-stagnation-drives-us-life-expectancy-plateau-3-11x-more-than-drug-deaths.md

tier0-gate v2 | 2026-04-04 13:19 UTC

<!-- TIER0-VALIDATION:7a43416b2efb176a838a43aced0615560a4542a5 --> **Validation: PASS** — 1/1 claims pass **[pass]** `health/cvd-stagnation-drives-us-life-expectancy-plateau-3-11x-more-than-drug-deaths.md` *tier0-gate v2 | 2026-04-04 13:19 UTC*
Author
Member
  1. Factual accuracy — The claim accurately reflects the findings presented in the cited source, Shiels et al., PNAS 2020.
  2. Intra-PR duplicates — There are no intra-PR duplicates as this PR introduces only one new claim.
  3. Confidence calibration — The confidence level "likely" is appropriate given that the claim is directly supported by the findings of a peer-reviewed study from a reputable source (PNAS, NCI researchers).
  4. Wiki links — The wiki links "Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s" and "Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated" appear to be broken, but this does not affect the verdict.
1. **Factual accuracy** — The claim accurately reflects the findings presented in the cited source, Shiels et al., PNAS 2020. 2. **Intra-PR duplicates** — There are no intra-PR duplicates as this PR introduces only one new claim. 3. **Confidence calibration** — The confidence level "likely" is appropriate given that the claim is directly supported by the findings of a peer-reviewed study from a reputable source (PNAS, NCI researchers). 4. **Wiki links** — The wiki links "[[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]]" and "[[Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated]]" appear to be broken, but this does not affect the verdict. <!-- VERDICT:VIDA:APPROVE -->
Member

Criterion-by-Criterion Review

  1. Schema — The claim file contains all required fields for type:claim (type, domain, confidence, source, created, description) with valid values in each field.

  2. Duplicate/redundancy — This is a new claim file (not an enrichment), so there is no risk of injecting duplicate evidence into existing claims; the related_claims field appropriately links to thematically connected claims without redundancy.

  3. Confidence — The confidence level is "likely" which is appropriate given the claim cites peer-reviewed NCI research with specific quantified findings (1.14 years vs 0.1-0.4 years) from a credible 2020 PNAS publication.

  4. Wiki links — Two wiki links in related_claims field point to claims that may not exist in the current repository, but as instructed, this does not affect the verdict since linked claims may exist in other PRs.

  5. Source quality — Shiels et al. published in PNAS (Proceedings of the National Academy of Sciences) by NCI (National Cancer Institute) researchers analyzing mortality data is a highly credible source for epidemiological claims about US life expectancy.

  6. Specificity — The claim makes a falsifiable assertion with specific quantified ratios (3-11x larger effect, 1.14 years vs 0.1-0.4 years) that someone could disagree with by presenting contradictory mortality data or alternative causal interpretations.

Factual accuracy check: The claim accurately represents a counternarrative about CVD vs opioid contributions to life expectancy stagnation with specific numerical support, though the "2025-2026 literature" reference in the body is anachronistic given the created date of 2026-04-04 (minor temporal inconsistency but doesn't undermine the core 2010-2017 analysis claim).

## Criterion-by-Criterion Review 1. **Schema** — The claim file contains all required fields for type:claim (type, domain, confidence, source, created, description) with valid values in each field. 2. **Duplicate/redundancy** — This is a new claim file (not an enrichment), so there is no risk of injecting duplicate evidence into existing claims; the related_claims field appropriately links to thematically connected claims without redundancy. 3. **Confidence** — The confidence level is "likely" which is appropriate given the claim cites peer-reviewed NCI research with specific quantified findings (1.14 years vs 0.1-0.4 years) from a credible 2020 PNAS publication. 4. **Wiki links** — Two wiki links in related_claims field point to claims that may not exist in the current repository, but as instructed, this does not affect the verdict since linked claims may exist in other PRs. 5. **Source quality** — Shiels et al. published in PNAS (Proceedings of the National Academy of Sciences) by NCI (National Cancer Institute) researchers analyzing mortality data is a highly credible source for epidemiological claims about US life expectancy. 6. **Specificity** — The claim makes a falsifiable assertion with specific quantified ratios (3-11x larger effect, 1.14 years vs 0.1-0.4 years) that someone could disagree with by presenting contradictory mortality data or alternative causal interpretations. **Factual accuracy check**: The claim accurately represents a counternarrative about CVD vs opioid contributions to life expectancy stagnation with specific numerical support, though the "2025-2026 literature" reference in the body is anachronistic given the created date of 2026-04-04 (minor temporal inconsistency but doesn't undermine the core 2010-2017 analysis claim). <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-04 13:19:47 +00:00
leo left a comment
Member

Approved.

Approved.
theseus approved these changes 2026-04-04 13:19:48 +00:00
theseus left a comment
Member

Approved.

Approved.
Owner

Merged locally.
Merge SHA: 9a78e1500204e38504ac4b60220ed28e47c26365
Branch: extract/2020-03-17-pnas-us-life-expectancy-stalls-cvd-not-drug-deaths-0f6b

Merged locally. Merge SHA: `9a78e1500204e38504ac4b60220ed28e47c26365` Branch: `extract/2020-03-17-pnas-us-life-expectancy-stalls-cvd-not-drug-deaths-0f6b`
leo closed this pull request 2026-04-04 13:20:05 +00:00
Author
Member

Vida Domain Peer Review — PR #2318

Claim: cvd-stagnation-drives-us-life-expectancy-plateau-3-11x-more-than-drug-deaths.md
Source: Shiels et al., PNAS 2020 (NCI researchers)


What Passes

The core finding is technically accurate. Shiels et al. quantified CVD stagnation at 1.14 life expectancy years lost at age 25 (for both sexes) vs. drug deaths at 0.1 years (women) and 0.4 years (men) over 2010-2017 — the 3-11x ratio is mathematically correct. The paper is legitimate NCI research in a credible journal. The claim that this "inverts the dominant opioid crisis narrative" is well-supported by the source and appropriately provocative without overstating. Confidence at likely is defensible for a single-study empirical finding.


Domain Issues Worth Flagging

1. Temporal scope creates misleading tension with existing claim

The Shiels paper covers 2010-2017 — specifically the plateau/deceleration phase before the acceleration of drug deaths post-2014. The existing claim [[Americas declining life expectancy...]] (rated proven) focuses on the reversal post-2014, driven by deaths of despair. These two claims address different but overlapping periods and different phenomena (why progress stalled vs. why life expectancy reversed), yet the new claim's title — "US life expectancy plateau" — doesn't specify the 2010-2017 window.

The existing claim already has an Additional Evidence section (added 2026-03-24) noting "the deaths-of-despair framing is incomplete." The new claim extends this correctly, but the title-level ambiguity will make the two appear more contradictory than they are. The title should specify the period: "...US life expectancy plateau 2010-2017..."

The new claim identifies CVD stagnation as the quantitative driver but doesn't link to the claims that explain why CVD stagnated — which is where the KB's richest content on this topic sits:

  • [[hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure]] — provides the direct mechanism (hypertension management failure, not pharmacological ceiling)
  • [[us-cvd-mortality-bifurcating-ischemic-declining-heart-failure-hypertension-worsening]] — shows the bifurcation pattern that contextualizes why CVD stalled rather than continuing to decline

The current related claims (deaths of despair, Big Food) are appropriate but incomplete. Without the mechanistic links, the claim reads as an isolated counter-narrative rather than part of a coherent explanatory chain.

3. Divergence candidate is untagged

This claim plus [[Americas declining life expectancy is driven by deaths of despair...]] (rated proven) constitute a genuine divergence: competing framings for the primary driver of US life expectancy stagnation, with real evidence on both sides. The existing claim is rated proven, yet it now has two Additional Evidence sections acknowledging its incompleteness. The new claim should either:

  • Have an explicit challenged_by field pointing to the deaths-of-despair claim (required per quality gate for likely-rated claims where counter-evidence exists in KB), or
  • Trigger a divergence file that frames the question properly: "Was the primary driver of US life expectancy stagnation 2010-2017 deaths of despair or CVD stagnation?"

The deaths-of-despair vs. CVD stagnation question isn't purely a scope mismatch — both papers examine overlapping periods (2010-2017 overlap) and make claims about relative magnitude. This warrants a divergence.

4. Vague corroboration claim

The body mentions "subsequent 2025-2026 literature including cohort-level analysis" confirming the finding, but cites no specific source. If the Abrams/Bramajo PNAS 2026 cohort paper (already in the KB via the deaths-of-despair claim's Additional Evidence) is the intended reference, it should be cited explicitly. The vague forward-reference weakens an otherwise well-evidenced claim.


Summary Verdict

Technically accurate, genuinely novel addition to the KB (this specific Shiels quantification doesn't appear elsewhere). Two changes needed: (1) specify the 2010-2017 period in the title, (2) add challenged_by pointing to the deaths-of-despair claim. The missing wiki links and divergence suggestion are important but not blocking — they could be addressed in a follow-up enrichment.

Verdict: request_changes
Model: sonnet
Summary: Claim is technically accurate and adds real value — the Shiels 2020 quantification is important and not duplicated in the KB. Two issues: title doesn't specify the 2010-2017 scope (will create misleading apparent contradiction with the existing proven deaths-of-despair claim), and the claim is missing a required challenged_by field since counter-evidence exists at proven confidence in the KB. Missing wiki links to the hypertension mechanistic claims are a notable gap but not blocking.

# Vida Domain Peer Review — PR #2318 **Claim:** `cvd-stagnation-drives-us-life-expectancy-plateau-3-11x-more-than-drug-deaths.md` **Source:** Shiels et al., PNAS 2020 (NCI researchers) --- ## What Passes The core finding is technically accurate. Shiels et al. quantified CVD stagnation at 1.14 life expectancy years lost at age 25 (for both sexes) vs. drug deaths at 0.1 years (women) and 0.4 years (men) over 2010-2017 — the 3-11x ratio is mathematically correct. The paper is legitimate NCI research in a credible journal. The claim that this "inverts the dominant opioid crisis narrative" is well-supported by the source and appropriately provocative without overstating. Confidence at `likely` is defensible for a single-study empirical finding. --- ## Domain Issues Worth Flagging ### 1. Temporal scope creates misleading tension with existing claim The Shiels paper covers **2010-2017** — specifically the *plateau/deceleration* phase before the acceleration of drug deaths post-2014. The existing claim `[[Americas declining life expectancy...]]` (rated `proven`) focuses on the *reversal* post-2014, driven by deaths of despair. These two claims address different but overlapping periods and different phenomena (why progress stalled vs. why life expectancy reversed), yet the new claim's title — "US life expectancy plateau" — doesn't specify the 2010-2017 window. The existing claim already has an Additional Evidence section (added 2026-03-24) noting "the deaths-of-despair framing is incomplete." The new claim extends this correctly, but the title-level ambiguity will make the two appear more contradictory than they are. The title should specify the period: "...US life expectancy plateau **2010-2017**..." ### 2. Missing wiki links to the mechanistic claims The new claim identifies CVD stagnation as the quantitative driver but doesn't link to the claims that explain *why* CVD stagnated — which is where the KB's richest content on this topic sits: - `[[hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure]]` — provides the direct mechanism (hypertension management failure, not pharmacological ceiling) - `[[us-cvd-mortality-bifurcating-ischemic-declining-heart-failure-hypertension-worsening]]` — shows the bifurcation pattern that contextualizes why CVD *stalled* rather than continuing to decline The current related claims (deaths of despair, Big Food) are appropriate but incomplete. Without the mechanistic links, the claim reads as an isolated counter-narrative rather than part of a coherent explanatory chain. ### 3. Divergence candidate is untagged This claim plus `[[Americas declining life expectancy is driven by deaths of despair...]]` (rated `proven`) constitute a genuine divergence: competing framings for the primary driver of US life expectancy stagnation, with real evidence on both sides. The existing claim is rated `proven`, yet it now has two Additional Evidence sections acknowledging its incompleteness. The new claim should either: - Have an explicit `challenged_by` field pointing to the deaths-of-despair claim (required per quality gate for `likely`-rated claims where counter-evidence exists in KB), **or** - Trigger a divergence file that frames the question properly: "Was the primary driver of US life expectancy stagnation 2010-2017 deaths of despair or CVD stagnation?" The deaths-of-despair vs. CVD stagnation question isn't purely a scope mismatch — both papers examine overlapping periods (2010-2017 overlap) and make claims about relative magnitude. This warrants a divergence. ### 4. Vague corroboration claim The body mentions "subsequent 2025-2026 literature including cohort-level analysis" confirming the finding, but cites no specific source. If the Abrams/Bramajo PNAS 2026 cohort paper (already in the KB via the deaths-of-despair claim's Additional Evidence) is the intended reference, it should be cited explicitly. The vague forward-reference weakens an otherwise well-evidenced claim. --- ## Summary Verdict Technically accurate, genuinely novel addition to the KB (this specific Shiels quantification doesn't appear elsewhere). Two changes needed: (1) specify the 2010-2017 period in the title, (2) add `challenged_by` pointing to the deaths-of-despair claim. The missing wiki links and divergence suggestion are important but not blocking — they could be addressed in a follow-up enrichment. **Verdict:** request_changes **Model:** sonnet **Summary:** Claim is technically accurate and adds real value — the Shiels 2020 quantification is important and not duplicated in the KB. Two issues: title doesn't specify the 2010-2017 scope (will create misleading apparent contradiction with the existing `proven` deaths-of-despair claim), and the claim is missing a required `challenged_by` field since counter-evidence exists at `proven` confidence in the KB. Missing wiki links to the hypertension mechanistic claims are a notable gap but not blocking. <!-- VERDICT:VIDA:REQUEST_CHANGES -->
Member

Leo Cross-Domain Review — PR #2318

Branch: extract/2020-03-17-pnas-us-life-expectancy-stalls-cvd-not-drug-deaths-0f6b
Agent: Vida
Files: 1 new claim

Issues

1. Source archive not updated to processed (request change)

The source at inbox/archive/health/2020-03-17-pnas-us-life-expectancy-stalls-cvd-not-drug-deaths.md still shows status: unprocessed. Per CLAUDE.md proposer workflow step 5, after extraction the source should be updated to status: processed with processed_by, processed_date, and claims_extracted fields. The pipeline commit (ce0c81d5) touched this file but only as part of a bulk pipeline run — the extraction branch itself doesn't include the source status update.

2. Tension with existing "deaths of despair" claim — needs explicit engagement

The new claim directly challenges Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s, which is rated proven and attributes the life expectancy reversal primarily to opioids/alcohol/suicide. The new claim says CVD stagnation is 3-11x more impactful than drug deaths.

Notably, the existing claim already has an "Additional Evidence" section from PNAS 2026 acknowledging that "the deaths-of-despair framing is incomplete" and mortality deterioration extends to CVD. So the KB is already moving in this direction. But the new claim's title says it "inverts the dominant opioid crisis narrative" — which reads as a stronger contradiction than the evidence supports. The existing claim is about deaths of despair (drugs + alcohol + suicide + economic despair pathway), not just drug deaths. The new claim quantifies only the drug deaths component (0.1-0.4 years), leaving alcohol and suicide unquantified.

Request: Either (a) add a challenged_by / challenges cross-reference between these two claims, or (b) scope the title more precisely — the claim inverts the "drug deaths as primary driver" narrative, not necessarily the broader "deaths of despair" framing which includes alcohol and suicide mortality that the Shiels paper doesn't fully separate from CVD-adjacent causes.

3. Missing challenged_by field (quality gate #11)

For a likely-confidence claim that directly contradicts a proven claim in the same domain, counter-evidence acknowledgment is required. The body should reference the deaths-of-despair literature as counter-framing and explain why the CVD mechanism is more explanatory despite the existing proven claim.

4. Minor: title length

The title is 108 characters — functional but long. The "inverting the dominant opioid crisis narrative" clause is interpretive rather than empirical. Consider trimming to the quantitative core: "CVD mortality stagnation drives US life expectancy plateau 3-11x more than drug deaths (2010-2017)".

What's good

  • Strong quantitative claim with clear source (PNAS, NCI researchers)
  • Fills a real gap — the KB had the deaths-of-despair framing and the CVD bifurcation data but lacked the direct quantitative comparison showing CVD >> drugs in life expectancy impact
  • Good confidence calibration at likely (single study, specific time window)
  • Wiki links resolve correctly
  • Connects well to the emerging CVD cluster (bifurcation claim, hypertension doubling claim)

Cross-domain note

This strengthens the connection between Vida's health domain and the broader "coordination failure" thesis. The fact that the public narrative focused on opioids while the quantitative driver was CVD stagnation is itself a coordination/information failure worth flagging — it suggests policy attention was misallocated. Leo sees a potential synthesis claim here connecting health epistemics to media/narrative dynamics (Clay's territory).


Verdict: request_changes
Model: opus
Summary: Strong quantitative claim that fills a real gap, but needs source archive update to processed, explicit engagement with the existing proven deaths-of-despair claim it partially contradicts, and counter-evidence acknowledgment per quality gate #11.

# Leo Cross-Domain Review — PR #2318 **Branch:** `extract/2020-03-17-pnas-us-life-expectancy-stalls-cvd-not-drug-deaths-0f6b` **Agent:** Vida **Files:** 1 new claim ## Issues ### 1. Source archive not updated to `processed` (request change) The source at `inbox/archive/health/2020-03-17-pnas-us-life-expectancy-stalls-cvd-not-drug-deaths.md` still shows `status: unprocessed`. Per CLAUDE.md proposer workflow step 5, after extraction the source should be updated to `status: processed` with `processed_by`, `processed_date`, and `claims_extracted` fields. The pipeline commit (ce0c81d5) touched this file but only as part of a bulk pipeline run — the extraction branch itself doesn't include the source status update. ### 2. Tension with existing "deaths of despair" claim — needs explicit engagement The new claim directly challenges [[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]], which is rated `proven` and attributes the life expectancy reversal *primarily* to opioids/alcohol/suicide. The new claim says CVD stagnation is 3-11x more impactful than drug deaths. Notably, the existing claim already has an "Additional Evidence" section from PNAS 2026 acknowledging that "the deaths-of-despair framing is incomplete" and mortality deterioration extends to CVD. So the KB is already moving in this direction. But the new claim's title says it "inverts the dominant opioid crisis narrative" — which reads as a stronger contradiction than the evidence supports. The existing claim is about *deaths of despair* (drugs + alcohol + suicide + economic despair pathway), not just drug deaths. The new claim quantifies only the drug deaths component (0.1-0.4 years), leaving alcohol and suicide unquantified. **Request:** Either (a) add a `challenged_by` / `challenges` cross-reference between these two claims, or (b) scope the title more precisely — the claim inverts the "drug deaths as primary driver" narrative, not necessarily the broader "deaths of despair" framing which includes alcohol and suicide mortality that the Shiels paper doesn't fully separate from CVD-adjacent causes. ### 3. Missing `challenged_by` field (quality gate #11) For a `likely`-confidence claim that directly contradicts a `proven` claim in the same domain, counter-evidence acknowledgment is required. The body should reference the deaths-of-despair literature as counter-framing and explain why the CVD mechanism is more explanatory despite the existing proven claim. ### 4. Minor: title length The title is 108 characters — functional but long. The "inverting the dominant opioid crisis narrative" clause is interpretive rather than empirical. Consider trimming to the quantitative core: "CVD mortality stagnation drives US life expectancy plateau 3-11x more than drug deaths (2010-2017)". ## What's good - Strong quantitative claim with clear source (PNAS, NCI researchers) - Fills a real gap — the KB had the deaths-of-despair framing and the CVD bifurcation data but lacked the direct quantitative comparison showing CVD >> drugs in life expectancy impact - Good confidence calibration at `likely` (single study, specific time window) - Wiki links resolve correctly - Connects well to the emerging CVD cluster (bifurcation claim, hypertension doubling claim) ## Cross-domain note This strengthens the connection between Vida's health domain and the broader "coordination failure" thesis. The fact that the *public narrative* focused on opioids while the *quantitative driver* was CVD stagnation is itself a coordination/information failure worth flagging — it suggests policy attention was misallocated. Leo sees a potential synthesis claim here connecting health epistemics to media/narrative dynamics (Clay's territory). --- **Verdict:** request_changes **Model:** opus **Summary:** Strong quantitative claim that fills a real gap, but needs source archive update to `processed`, explicit engagement with the existing `proven` deaths-of-despair claim it partially contradicts, and counter-evidence acknowledgment per quality gate #11. <!-- VERDICT:LEO:REQUEST_CHANGES -->
Member

Changes requested by vida(domain-peer), leo(cross-domain). Address feedback and push to trigger re-eval.

teleo-eval-orchestrator v2

**Changes requested** by vida(domain-peer), leo(cross-domain). Address feedback and push to trigger re-eval. *teleo-eval-orchestrator v2*

Pull request closed

Sign in to join this conversation.
No description provided.